Skip to Content

CS Diagnostics Corp FZRO

Morningstar Rating
$0.39 +0.22 (126.09%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FZRO is trading at a 47% discount.
Price
$0.39
Fair Value
$7.88
Uncertainty
Extreme
1-Star Price
$8.65
5-Star Price
$5.15
Economic Moat
Ybms
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FZRO is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.17
Day Range
$0.170.39
52-Week Range
$0.026.25
Bid/Ask
$0.16 / $0.36
Market Cap
$105,523.86
Volume/Avg
821 / 2,295

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

CS Diagnostics Corp is a pharmaceutical international wholesaler and manufacturer of medical technology. The current management has been supplying national and international specialists, practices, clinics as well as ministries of health. Its focus is on improving therapy results and reducing its side effects.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees

Valuation

Metric
FZRO
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
FZRO
Quick Ratio
0.02
Current Ratio
0.02
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
FZRO
Return on Assets (Normalized)
−577.98%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesNqqmjsbtvFtttzr$182.7 Bil
SYK
Stryker CorpYgcxlnclfnYmhp$124.6 Bil
MDT
Medtronic PLCSnmxqcmNjpwzyr$105.2 Bil
BSX
Boston Scientific CorpVzkkljpckLkgrf$99.0 Bil
DXCM
DexCom IncWsvdzylkBsrl$51.8 Bil
EW
Edwards Lifesciences CorpTcbfwwnwyxSgxjcpq$51.7 Bil
ZBH
Zimmer Biomet Holdings IncHmysbqhrzzNnq$24.5 Bil
ALGN
Align Technology IncPthrjmrjxClmsf$22.5 Bil
PHG
Koninklijke Philips NV ADRJnsljmqhtSrgqdjs$18.3 Bil
PODD
Insulet CorpLsjcjdfjvkShrnvg$11.6 Bil

Sponsor Center